Poor radiotherapy compliance predicts persistent regional disease in advanced head/neck cancer

Laryngoscope

Volumn 119, Issue 3, 2009, Pages 528-533

  Patel, Urjeet A ^a,b,c   Patadia, Monica O ^a   Holloway, Nathaniel ^b   Rosen, Fred ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Jr Hospital of Cook County   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Compliance; County hospital; Head and neck cancer; Neck dissection; Radiation; Underserved populations

Indexed keywords

CARBOPLATIN; CISPLATIN;

ADULT; ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CLINICAL ARTICLE; COHORT ANALYSIS; DISEASE SEVERITY; DRUG SUBSTITUTION; FEMALE; HEAD AND NECK CANCER; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HYPOPHARYNX CANCER; LARYNX CANCER; MALE; MOUTH CANCER; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NECK DISSECTION; OROPHARYNX CANCER; PATIENT COMPLIANCE; PATIENT IDENTIFICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TERTIARY HEALTH CARE; TREATMENT DURATION; TREATMENT RESPONSE; URBAN AREA; CANCER STAGING; COMPARATIVE STUDY; FOLLOW UP; HEAD AND NECK TUMOR; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; STATISTICS; TREATMENT OUTCOME; URBAN POPULATION;

CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM STAGING; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; TREATMENT OUTCOME; URBAN POPULATION;

EID: 64849099208     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.20072     Document Type: Article

References (14)

1. Nouraei SA, Upile T., Al-Yaghchi C., Sandhu GS, Stewart S., Clarke PM, Sandison A. Role of planned postchemoradiotherapy selective neck dissection in the multimodality management of head and neck cancer. Laryngoscope 2008; 118(5) :797-803.
2. Stenson KM, Haraf DJ, Pelzer H., Recant W., Kies MS, Weichselbaum RR, Vokes EE. The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection. Arch Otolaryngol 2000; 126(8) :950-956.
3. Patel UA, Thakkar KH, Holloway N. Patient compliance to radiation for advanced head and neck cancer at a tertiary care county hospital. Laryngoscope 2008; 118(3): 428-432.
4. Patel UA, Lynn-Macrae A., Rosen F., Holloway N., Kern R. Advanced stage of head and neck cancer at a tertiarycare county hospital. Laryngoscope 2006; 116(8) :1473-1477.
5. Pajak TF, Laramore GE, Marcial VA, et al. Elapsed treatment days-a critical item for radiotherapy quality control review in head and neck trials: RTOG report. Int J Radiat Oncol Biol Phys 1991; 20:13-20.
6. Cathcart CS, Dunican A., Halpern JN. Patterns of delivery of radiation therapy in an inner-city population of head and neck cancer patients: an analysis of compliance and end results. J Medicine 1997; 28 (5-6) :275-284.
7. American Joint Committee on Cancer. AJCC Cancer Staging Manual. 6th ed. Philadelphia, PA: Lippincott-Raven Publishers; 2002.
8. Hitchcock YJ, Bentz BG, Sharma PK, et al. Planned neck dissection after definitive radiotherapy or chemoradiation for base of tongue cancers. Otolaryngol Head Neck Surg 2007; 137(3) :422-427.
9. Pfister DG, Strong E., Harrison L., et al. Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer. J Clin Oncol 1991; 9(5) :850-859.
10. Hoffman HT, Porter K., Karnell LH, et al. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 2006; 116 (9 Pt 2 Suppl 111) :1-13.
11. Stenson KM, Huo D., Blair E., Cohen EE, Argiris A., Haraf DJ, Vokes EE. Planned post-chemoradiation neck dissection: significance of radiation dose. Laryngoscope 2006; 116(1) :33-36.
12. Goguen LA, Posner MR, Tishler RB, et al. Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 2006; 132:526-531.
13. Argiris A., Stenson KM, Brockstein BE, et al. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck 2004; 26(5) :447-455.
14. Simon C., Goepfert H., Rosenthal DI, et al. Presence of malignant tumor cells in persistent neck disease after radiotherapy for advanced squamous cell carcinoma of the oropharynx is associated with poor survival. Eur Arch Otorhinolaryngol 2006; 263(4) :313-318.